Next Article in Journal
Bifidobacteria and Mucosal-Associated Invariant T (MAIT) Cells: A New Approach to Colorectal Cancer Prevention?
Previous Article in Journal
Evidence of Differences and Discrimination in the Delivery of Care: Colorectal Screening in Healthy People and in the Care and Surveillance of Patients with Inflammatory Bowel Disease
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Gastrointestinal Disorders
Volume 1
Issue 2
10.3390/gidisord1020021
gastrointestdisord-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Asymptomatic Inflammatory Bowel Disease and Colorectal Cancer Screening Programs: How Common Is It and What Should be Done About It?

by
Affifa Farrukh
1 and
John F. Mayberry
2,*
1
Digestive Diseases Centre, University Hospitals of Leicester, Gwendolen Road, Leicester LE5 4PW, UK
2
Department of Digestive Diseases, Leicester General Hospital, Gwendolen Road, Leicester LE5 4PW, UK
*
Author to whom correspondence should be addressed.
Gastrointest. Disord. 2019, 1(2), 261-265; https://doi.org/10.3390/gidisord1020021
Submission received: 24 April 2019 / Revised: 5 May 2019 / Accepted: 16 May 2019 / Published: 17 May 2019
Versions Notes

Abstract

The growing international popularity of screening programs for the early detection of pre-cancerous changes or early cancer in the colon has brought to the fore the issue of people with asymptomatic inflammatory bowel disease. What are the legal and clinical responsibilities for endoscopists and managers of screening programs towards such patients? This review assesses the magnitude of the problem and discusses the legal responsibilities, including human rights issues. In addition, it discusses whether such patients who do not have symptoms should be given active treatment.
Keywords: inflammatory bowel disease; healthy people; colorectal cancer screening programs; law; human rights inflammatory bowel disease; healthy people; colorectal cancer screening programs; law; human rights

Share and Cite

MDPI and ACS Style

Farrukh, A.; Mayberry, J.F. Asymptomatic Inflammatory Bowel Disease and Colorectal Cancer Screening Programs: How Common Is It and What Should be Done About It? Gastrointest. Disord. 2019, 1, 261-265. https://doi.org/10.3390/gidisord1020021

AMA Style

Farrukh A, Mayberry JF. Asymptomatic Inflammatory Bowel Disease and Colorectal Cancer Screening Programs: How Common Is It and What Should be Done About It? Gastrointestinal Disorders. 2019; 1(2):261-265. https://doi.org/10.3390/gidisord1020021

Chicago/Turabian Style

Farrukh, Affifa, and John F. Mayberry. 2019. "Asymptomatic Inflammatory Bowel Disease and Colorectal Cancer Screening Programs: How Common Is It and What Should be Done About It?" Gastrointestinal Disorders 1, no. 2: 261-265. https://doi.org/10.3390/gidisord1020021

APA Style

Farrukh, A., & Mayberry, J. F. (2019). Asymptomatic Inflammatory Bowel Disease and Colorectal Cancer Screening Programs: How Common Is It and What Should be Done About It? Gastrointestinal Disorders, 1(2), 261-265. https://doi.org/10.3390/gidisord1020021

Article Metrics

Back to TopTop